Jonsson Comprehensive Cancer Center's Dr. Dennis Slamon and his "dream team" of researchers are profiled for CBS 2 News Central. He discusses how pioneering research at UCLA is shaking up traditional methods in breast cancer therapy, targeting and tailoring treatment for patients by cancer subtype.
Antoni Ribas, M.D. of the UCLA Jonsson Comprehensive Cancer Center is involved in trials testing new cancer drugs targeting the cell surface molecule called PD-L1, and the immune cell receptors PD1. Early data from these trails involving non-small cell lung cancer, renal cancer and melanoma have demonstrated impressive results that can lead to new treatments for the disease. In the video interview, Dr. Ribas explains the trial test data published so far, and previews new data to be seen at the upcoming American Society of Clinical Oncology (ASCO) meeting.
Dr. Judith Gasson, Director of UCLA's Jonsson Comprehensive Cancer Center (JCCC), discusses research areas within the JCCC that are making tremendous headway in cancer treatment and detection. Advancements in stem cell research, nanotechnology, imaging, and translational research at the JCCC are making measurable progress and saving lives every day. To learn more about the JCCC, visit www.cancer.ucla.edu.
Drs. Judith Gasson, Lauren Pinter-Brown, Rich Finn and Antoni Ribas discuss research advances at UCLAs Jonsson Comprehensive Cancer Center. Three patients share their stories of battling cancer. This video was produced and directed by filmmaker Lawrence Kasdan. The music was composed by Grammy Award winner James Newton Howard.
UPDATE: Darrell Cantor suffered a recurrence of his cancer and, despite treatment, he passed away on Saturday, August 24, 2009. Through his participation in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center, Cantor lived longer and enjoyed a better quality of life than the average liver cancer patient. His participation also helped move cancer research forward. We thank him.
UCLA's Jonsson Comprehensive Cancer Center has over 235 physicians and scientists who have played crucial roles in the development of FDA approved cancer therapies for patients world-wide. The JCCC provides the latest in experimental cancer treatments and hundreds of clinical trials.
Scientists from UCLA's Jonsson Comprehensive Cancer Center, led by pioneering cancer researchers Drs. Dennis Slamon and Zev Wainberg, are bringing stem cell science directly to cancer patients with an exciting new clinical trial scheduled to begin in early 2014. Partially funded by the California Institute of Regenerative Medicine (CIRM), the project builds on Slamon's previous work to develop a drug that targets tumor initiating cells, that was conducted with Wainberg. In this NBC 4 news piece, Slamon and Wainberg discuss this breakthrough research, and the powerful potential this anti-cancer drug has in battling the disease.
Doctors and UCLA's Jonsson Comprehensive Cancer Center were able to save the life of Kevin Carlberg who at the age of 25 was diagnosed with glioblastoma.
UPDATE 8/31/2009: Kevin Carlberg suffered a recurrence of his cancer and, despite treatment, he passed away on Saturday, August 29, 2009. Through his participation in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center, Carlberg lived about four times longer than the average glioblastoma patient. His participation also helped move cancer research forward. We thank him.